196 related articles for article (PubMed ID: 30935778)
1. GPR15 is not critically involved in the regulation of murine psoriasiform dermatitis.
Sezin T; Kempen L; Meyne LM; Mousavi S; Zillikens D; Sadik CD
J Dermatol Sci; 2019 Apr; 94(1):196-204. PubMed ID: 30935778
[TBL] [Abstract][Full Text] [Related]
2.
Bezdek S; Leng L; Busch H; Mousavi S; Rades D; Dahlke M; Zillikens D; Bucala R; Sadik CD
Front Immunol; 2018; 9():2262. PubMed ID: 30333830
[TBL] [Abstract][Full Text] [Related]
3. Anti-IL-17A and IL-23p19 antibodies but not anti-TNFα antibody induce expansion of regulatory T cells and restoration of their suppressive function in imiquimod-induced psoriasiform dermatitis.
Shimizu T; Kamata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
J Dermatol Sci; 2019 Sep; 95(3):90-98. PubMed ID: 31362906
[TBL] [Abstract][Full Text] [Related]
4. Fingolimod ameliorates imiquimod-induced psoriasiform dermatitis by sequestrating interleukin-17-producing ?d T cells in secondary lymph nodes.
Okura I; Kamata M; Asano Y; Mitsui A; Shimizu T; Sato S; Tada Y
J Dermatol Sci; 2021 May; 102(2):116-125. PubMed ID: 33888401
[TBL] [Abstract][Full Text] [Related]
5. Forward genetics and functional analysis highlight Itga11 as a modulator of murine psoriasiform dermatitis.
Bieber K; Bezdek S; Gupta Y; Vorobyev A; Sezin T; Gross N; Prüssmann J; Sayegh JP; Becker M; Mousavi S; Hdnah A; Künzel S; Ibrahim SM; Ludwig RJ; Gullberg D; Sadik CD
J Pathol; 2023 Oct; 261(2):184-197. PubMed ID: 37565309
[TBL] [Abstract][Full Text] [Related]
6. Capsaicin attenuates imiquimod-induced epidermal hyperplasia and cutaneous inflammation in a murine model of psoriasis.
Chan TC; Lee MS; Huang WC; Chang WY; Krueger JG; Tsai TF
Biomed Pharmacother; 2021 Sep; 141():111950. PubMed ID: 34328106
[TBL] [Abstract][Full Text] [Related]
7. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways.
Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H
J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840
[TBL] [Abstract][Full Text] [Related]
8. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice.
Van Belle AB; de Heusch M; Lemaire MM; Hendrickx E; Warnier G; Dunussi-Joannopoulos K; Fouser LA; Renauld JC; Dumoutier L
J Immunol; 2012 Jan; 188(1):462-9. PubMed ID: 22131335
[TBL] [Abstract][Full Text] [Related]
9. Is CCR6 Required for the Development of Psoriasiform Dermatitis in Mice?
Yu S; Wu X; Zhou Y; Han D; Anderson LS; Simon SI; Hwang ST; Imai Y
J Invest Dermatol; 2019 Feb; 139(2):485-488. PubMed ID: 30193756
[No Abstract] [Full Text] [Related]
10. Diet-induced obesity exacerbates imiquimod-mediated psoriasiform dermatitis in anti-PD-1 antibody-treated mice: Implications for patients being treated with checkpoint inhibitors for cancer.
Yu S; Wu X; Shi Z; Huynh M; Jena PK; Sheng L; Zhou Y; Han D; Wan YY; Hwang ST
J Dermatol Sci; 2020 Mar; 97(3):194-200. PubMed ID: 32044178
[TBL] [Abstract][Full Text] [Related]
11. IL-36α from Skin-Resident Cells Plays an Important Role in the Pathogenesis of Imiquimod-Induced Psoriasiform Dermatitis by Forming a Local Autoamplification Loop.
Hashiguchi Y; Yabe R; Chung SH; Murayama MA; Yoshida K; Matsuo K; Kubo S; Saijo S; Nakamura Y; Matsue H; Iwakura Y
J Immunol; 2018 Jul; 201(1):167-182. PubMed ID: 29794016
[TBL] [Abstract][Full Text] [Related]
12. Skin-penetrating methotrexate alleviates imiquimod-induced psoriasiform dermatitis via decreasing IL-17-producing gamma delta T cells.
Byamba D; Kim DY; Kim DS; Kim TG; Jee H; Kim SH; Park TY; Yang SH; Lee SK; Lee MG
Exp Dermatol; 2014 Jul; 23(7):492-6. PubMed ID: 24824846
[TBL] [Abstract][Full Text] [Related]
13. Extracellular ATP and IL-23 Form a Local Inflammatory Circuit Leading to the Development of a Neutrophil-Dependent Psoriasiform Dermatitis.
Diaz-Perez JA; Killeen ME; Yang Y; Carey CD; Falo LD; Mathers AR
J Invest Dermatol; 2018 Dec; 138(12):2595-2605. PubMed ID: 29870687
[TBL] [Abstract][Full Text] [Related]
14. Characterization of psoriasiform dermatitis induced by systemic injection of interleukin-23 minicircles in mice.
Leys L; Wang Y; Paulsboe S; Edelmayer R; Salte K; Wetter J; Namovic M; Phillips L; Dunstan R; Gauvin D; Donnelly-Roberts D; Su Z; Honore P; McGaraughty S
J Dermatol; 2019 Jun; 46(6):482-497. PubMed ID: 31062408
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-21 receptor signalling is not critically required for imiquimod-induced psoriasiform dermatitis in mice.
Kim HJ; Kim SH; Kim TG; Park JY; Lee M; Kim DS; Lee MG
Exp Dermatol; 2018 Feb; 27(2):191-195. PubMed ID: 29220875
[TBL] [Abstract][Full Text] [Related]
16. MAD ointment ameliorates Imiquimod-induced psoriasiform dermatitis by inhibiting the IL-23/IL-17 axis in mice.
OuYang Q; Pan Y; Luo H; Xuan C; Liu J; Liu J
Int Immunopharmacol; 2016 Oct; 39():369-376. PubMed ID: 27540765
[TBL] [Abstract][Full Text] [Related]
17. Reduction of CD18 promotes expansion of inflammatory γδ T cells collaborating with CD4+ T cells in chronic murine psoriasiform dermatitis.
Gatzka M; Hainzl A; Peters T; Singh K; Tasdogan A; Wlaschek M; Scharffetter-Kochanek K
J Immunol; 2013 Dec; 191(11):5477-88. PubMed ID: 24190659
[TBL] [Abstract][Full Text] [Related]
18. ACT1 Is Required for Murine IL-23-Induced Psoriasiform Inflammation Potentially Independent of E3 Ligase Activity.
Lipovsky A; Slivka PF; Su Z; Wang Y; Paulsboe S; Wetter J; Namovic MT; Gauvin D; Perron D; Gauld SB; McGaraughty S; Goedken ER
J Invest Dermatol; 2021 Jul; 141(7):1772-1779.e6. PubMed ID: 33548244
[TBL] [Abstract][Full Text] [Related]
19. IL-36 receptor antagonistic antibodies inhibit inflammatory responses in preclinical models of psoriasiform dermatitis.
Su Z; Paulsboe S; Wetter J; Salte K; Kannan A; Mathew S; Horowitz A; Gerstein C; Namovic M; Todorović V; Seagal J; Edelmayer RM; Viner M; Rinaldi L; Zhou L; Leys L; Huang S; Wang L; Sadhukhan R; Honore P; McGaraughty S; Scott VE
Exp Dermatol; 2019 Feb; 28(2):113-120. PubMed ID: 30417427
[TBL] [Abstract][Full Text] [Related]
20. Neutralization of IL-17C Reduces Skin Inflammation in Mouse Models of Psoriasis and Atopic Dermatitis.
Vandeghinste N; Klattig J; Jagerschmidt C; Lavazais S; Marsais F; Haas JD; Auberval M; Lauffer F; Moran T; Ongenaert M; Van Balen M; Dupont S; Lepescheux L; Garcia T; Härtle S; Eyerich K; Fallon PG; Brys R; Steidl S
J Invest Dermatol; 2018 Jul; 138(7):1555-1563. PubMed ID: 29474945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
